# Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

> **NCT01577914** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Fasting State

## Interventions

- **DRUG:** Carvedilol Tablets USP 12.5 mg
- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT01577914
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01577914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01577914, "Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01577914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*